-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CpsiLyiLTVriG311FmPW4Bx080h9o9ATZRKkQTgwEy4U3FyUD4cTICTL/4iDbWTZ WqOkelIp6UC4FMGRETrXxQ== 0000874015-06-000080.txt : 20061116 0000874015-06-000080.hdr.sgml : 20061116 20061116181438 ACCESSION NUMBER: 0000874015-06-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061114 FILED AS OF DATE: 20061116 DATE AS OF CHANGE: 20061116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ECKER DAVID J CENTRAL INDEX KEY: 0001073388 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 061224453 BUSINESS ADDRESS: BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2006-11-14 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073388 ECKER DAVID J C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 0 1 0 0 Vice President Common Stock 2006-11-14 2006-11-14 4 M 0 3900 6.81 A 3900 D Common Stock 2006-11-14 2006-11-14 4 S 0 3900 12.105 D 0 D Common Stock 34173 I By Trust Employee Stock Option (right to buy) 6.81 2006-11-14 2006-11-14 4 M 0 3900 0 D 2004-01-06 2010-01-05 Common Stock 3900 46100 D The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10-2-06. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10-2-06. /s/B. Lynne Parshall, Attorney-in-Fact 2006-11-16 -----END PRIVACY-ENHANCED MESSAGE-----